News
-
NAPSA jobs board
Monday | Jan 9 2017THE National Australian Pharmacy Students' Association (NAPSA) has announced the upcoming launch of a jobs board on its website, established via a collaborative partnership with iTherapeutics.
-
Nuts to babies
Monday | Jan 9 2017BABIES should be given peanut as early as four months old to reduce the risk of allergy by as much as 80%, according to new US guidance from the National Institute of Allergy and Infectious Diseases.
-
Its been a NICE year
Monday | Jan 9 2017THE UK's National Institute for Health and Care Excellence (NICE) has summarised highlights from its 2016 files with its articles tackling subjects as diverse as access to cancer products, tuberculosis guidelines, new diabetes type 2 treatment options, sepsis, stroke and drug pricing.
-
Back-to-school promo
Monday | Jan 9 2017SUPPLIERS are being alerted to the opportunity to participate in the upcoming Back-to-School Spotlight feature in Pharmacy Daily.
-
Ley in negative gear
Monday | Jan 9 2017AFTER initially defending every case that has been raised against her as "within entitlements", Health Minister Sussan Ley has now backpedalled and agreed to pay back the costs of her additional trips to the Gold Coast.
-
MRA GMP clearance process time drops
Monday | Jan 9 2017DEC 2016 saw the MRA GMP clearance application processing times drop to an average of 3.5 weeks, with 90% completed within 5.4 weeks.
-
Earlybird rego closing
Monday | Jan 9 2017APP2017 early bird registration is closing soon with delegates still able to access the $100-off deal if they register before 31 Jan.
-
Animal testing ban
Monday | Jan 9 2017TESTING of cosmetics on animals will be banned by the Department of Health under the government's plan to implement its pre-election promise on the matter.
-
Ezetimibe consult
Monday | Jan 9 2017THE public consultation on the draft Ezetimibe Post-market Review Report will open on 30 Jan 2017 and close at 5pm 10 Feb.
-
FDA hits deceptive adverts
Monday | Jan 9 2017ACCORDING to the US Food and Drug Administration (FDA), how well consumers and healthcare professionals are able to identify deceptive information plays a role in the agency's enforcement approach.
